# CBA PHARMA INC: Form D filings

CBA PHARMA INC, a biotechnology company in Lexington, KY, filed 5 Form D notices with the SEC between 2009 and 2015. The latest, on January 30, 2015, reports $100,000 sold of a $20 million offering to 1 investor.

Find out what CBA PHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CBA%20PHARMA%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CBA%20PHARMA%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fcba-pharma-inc-1143410)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CBA%20PHARMA%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CBA%20PHARMA%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fcba-pharma-inc-1143410)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Kentucky](https://specstream.ai/data/form-d/state/kentucky): 216 rows, by operating companies, filed since November 1, 2024, $10.80, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/kentucky
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 670 PERIMETER DR, Lexington, KY, 40517
- Phone: (859) 266-5757
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Nevada
- Year incorporated: 2012
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1143410

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 30, 2015 | New notice | $20,000,000 | $100,000 | $19,900,000 | 1 | Jan 20, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1143410/000146581815000001/0001465818-15-000001-index.htm) |
| Jun 6, 2013 | Amendment | $20,000,000 | $5,300,486 | $14,699,514 | 136 | Feb 13, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1143410/000146581813000004/0001465818-13-000004-index.htm) |
| Feb 28, 2012 | New notice | $20,000,000 | $539,125 | $19,460,875 | 41 | Feb 13, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1143410/000146581812000004/0001465818-12-000004-index.htm) |
| Apr 2, 2010 | Amendment | $10,000,000 | $3,928,115 | $6,071,885 | 149 | Mar 12, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1143410/000146581810000015/0001465818-10-000015-index.htm) |
| Mar 25, 2009 | New notice | $2,000,000 | $125,000 | $1,875,000 | 4 | Mar 12, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1143410/000114341009000003/0001143410-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| George P. Julius, Jr. | Executive Officer, Director |  |
| Stephen P. Whitman | Executive Officer, Director |  |
| Louis S. Carmichael | Executive Officer |  |
| Shelden K. LeBron | Executive Officer |  |
| Lawrence S. Martini | Executive Officer |  |
| Robert K. Oldham, MD | Executive Officer |  |
| Scott P. McKinney | Executive Officer, Director |  |
| Beth Diane Gudeman | Executive Officer, Director, Promoter |  |
| W. Michael Putnam | Executive Officer, Director, Promoter |  |
| Robert P. Granacher, Jr., MD, MBA | Director |  |

[Every Form D from the week of Jan 26, 2015](https://specstream.ai/data/form-d/week/2015-01-26) · [All recent filings in Kentucky](https://specstream.ai/data/form-d/state/kentucky) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what CBA PHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).